SEVERE VON WILLEBRAND DISEASE
Clinical trials for SEVERE VON WILLEBRAND DISEASE explained in plain language.
Never miss a new study
Get alerted when new SEVERE VON WILLEBRAND DISEASE trials appear
Sign up with your email to follow new studies for SEVERE VON WILLEBRAND DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare bleeding disease: study tests rVWF therapy
Disease control CompletedThis study tested a medicine called vonicog alfa (rVWF), sometimes given with another drug (ADVATE), to control bleeding in 47 children under 18 with severe von Willebrand disease. The treatment was given for 12-18 months, and doctors checked how well it stopped bleeding and if i…
Matched conditions: SEVERE VON WILLEBRAND DISEASE
Phase: PHASE3 • Sponsor: Baxalta now part of Shire • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for toddlers with rare bleeding disorder: wilate shows promise
Disease control CompletedThis study tested a medicine called wilate in 12 children under 6 years old with severe von Willebrand disease, a bleeding disorder. The goal was to see if regular infusions of wilate could prevent bleeding episodes over 12 months. Researchers measured how many bleeds occurred, h…
Matched conditions: SEVERE VON WILLEBRAND DISEASE
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New hope for rare bleeding disorder: Long-Term drug shows promise
Disease control CompletedThis study tested a drug called rVWF (Vonvendi) in 38 children and adults with severe von Willebrand disease, a bleeding disorder. The goal was to see if regular use of the drug could reduce the number of spontaneous bleeding episodes over a year. Participants received treatment …
Matched conditions: SEVERE VON WILLEBRAND DISEASE
Phase: PHASE3 • Sponsor: Baxalta now part of Shire • Aim: Disease control
Last updated Jun 26, 2026 12:56 UTC